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Abstract
Background: Renal cell carcinoma is the most common kidney tumor in adults and accounts for
approximately 3% of adult malignancies. An increased incidence of second malignancies has been
well documented in a number of different disorders, such as head and neck tumors, and hairy cell
leukemia. In addition, treatment associated second malignancies (usually leukemias and lymphomas
but also solid tumors) have been described in long term survivors of Hodgkin's lymphoma (HL),
Non Hodgkin's lymphoma and in various pediatric tumors.
Case presentation: We present the case of a 66 year-old woman with abdominal pain and
dyspnea. We performed a thorax CT scan that showed lymph nodes enlargement and subsequently
by presence of abdominal pain was performed an abdominal and pelvis CT scan that showed a right
kidney tumor of 4 × 5 cms besides of abdominal lymph nodes enlargement. A radical right
nephrectomy was designed and Hodgkin's lymphoma was diagnosed in the abdominal lymph nodes
while renal cell tumor exhibited a renal cell cancer. Patient received EVA protocol achieving
complete response.
Conclusion: We described the first case reported in the medical literature of the coexistence
between Hodgkin's lymphoma and renal cell cancer. Previous reports have shown the relationship
of lymphoid neoplasms with solid tumors, but they have usually described secondary forms of
cancer related to chemotherapy.
Background
Renal cell carcinoma is the most common kidney tumor
in adults and accounts for approximately 3% of adult
malignancies. The incidence is higher in male and appears
to be increased with cigarrete use and with obesity.[1,2]
There are both familial and sporadic forms of renal cell
carcinoma. Patients with von Hippel-Lindau (VHL) dis-
ease have a predisposition to develop bilateral renal
tumors among other malignancies, VHL gene has been
identified on the short arm of chromosome 3 (3p). [3] An
increased incidence of second malignancies has been well
documented in a number of different disorders, such as
head and neck tumors, [4,5] and hairy cell leukemia. [6]
In addition, treatment associated second malignancies
(usually leukemias and lymphomas but also solid
tumors) have been described in long term survivors of
Hodgkin's lymphoma (HL) [7,8], Non Hodgkin's lym-
phoma (NHL) [9-11] and in various pediatric tumors.
[12,13] There have been sporadic case reports of hairy cell
leukemia [14], chronic myeloid leukemia [15], multiple
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myeloma [16,17], NHL [18], HL [19] and testicular carci-
noma.[20] Nishikubo et al, described a serie of eight
patients with renal cell cancer and lymphoid malignan-
cies. One of these patients included the association
between renal cell cancer and HL but the presentation did
not occur at the same time . We describe the presentation
at the same time of both entities.
Case presentation
We present the case of a 66 year-old woman with history
of intense smoking (pack years of 50), diabetes mellitus
detected a prior year and COPD (Chronic obstructive pul-
monary disease) diagnosed 8 prior months. She came at
the emergency department to receive medical attention by
presenting fever, loss of weight and dyspnea. During the
initial evaluation was performed a thorax CT scan that
showed lymph nodes enlargement and subsequently by
presence of abdominal pain was performed an abdominal
and pelvis CT scan that showed a right kidney tumor of 4
× 5 cms besides of abdominal lymph nodes enlargement.
A radical right nephrectomy was designed, prior to surgery
we performed an spirometer study that revealed a moder-
ate obstruction pattern. The surgical procedure included
lymph nodes remotion. Histopathology study revealed
Hodgkin's lymphoma involving right kidney, abdominal
lymph nodes, ureter and liver. Immunostaining showed
positiveness for CD15, CD30 and LMP-1 while CD3, EMA
and ALK were negative. Histological study also reported a
clear renal cell cancer, degree II, involving only the right
kidney without extension to any other structure. Surgical
resection was complete and margins were negative for
cancer, diffuse glomerulosclerosis also was found. After
surgical procedure we did a bilateral bone marrow biopsy
that was negative for lymphoma. Staging studies showed
an IV b stage and 4 unfavorable factors (stage IV, hemo-
globin 7,2 g/dl, albumin 3.2 g/dl and lymphocytes <0.6)
Panel A and B shows a tumor involving the right kidney, measuring 4 × 5 cms Figure 1
Panel A and B shows a tumor involving the right kidney, measuring 4 × 5 cms. Panel C shows the CD 30 immunostain being 
positive in the neoplasms cells and Panel D shows a transitional area between renal cell cancer and Hodgkin's lymphoma.
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at diagnosis. We performed an echocardiography study
that revealed light enlargement of right cavities, diastolic
dysfunction and moderate pulmonary hypertension. The
patient received chemotherapy with a protocol called EVA
(etoposide, vinblastine and doxorubicin). After third cycle
we documented complete response, fact that was
obtained after completed the chemotherapy scheme. At
present she continues asymptomatic without evidence of
disease activity. We present a figure 1 that shows in the
panel A and B a tumor involving the right kidney, measur-
ing 4 × 5 cms while panel C shows the CD 30 immunos-
tain being positive in the neoplasms cells and panel D
shows a transitional area between renal cell cancer and
Hodgkin's lymphoma.
Conclusion
We described the first case reported in the medical litera-
ture of the coexistence between Hodgkin's lymphoma and
renal cell cancer. Previous reports have shown the rela-
tionship of lymphoid neoplasms with solid tumors, but
they have usually described secondary forms of cancer
related to chemotherapy. Nishikubo et al, reported a case
of a 63 year-old man that developed renal cell cancer 8
years after treatment for Hodgkin's lymphoma. [21] Due
to the presence of pulmonary hypertension and lung
injury related to COPD we decided to use the EVA proto-
col to treat this patient. Canellos et al, described the
employment of the EVA protocol to treat HL patients as a
first line therapy including advances stages, 51 patients,
even 12 with bulky disease received this protocol, 10 of
which received concomitant radiotherapy. [22] EVA pro-
tocol achieved complete response in 94% and free pro-
gression survival of 57% at 111 months since diagnosis.
Our patient is free disease at 2 months since the last course
of chemotherapy. She presented 4 unfavorable factors,
fact that predicts a possible recurrence. Multiple cancers
developing after chemotherapy and radiotherapy have
been described but we presented a peculiar case of simul-
taneous presentation of a solid tumor an HL. [23,24] It is
worthwhile to look for second malignancies and get addi-
tional biopsies in case of unclear finding. This coincidence
appears to be rare. We diagnosed annually 10 cases of
renal cell carcinoma and 20 cases a year of Hodgkin's lym-
phoma.
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